About the Psoriasis Treatments Session
Psoriasis is a chronic autoimmune skin condition characterized by red, scaly patches that can be itchy and uncomfortable. Treatments aim to manage symptoms and improve skin appearance. Topical therapies, such as corticosteroids and vitamin D analogues, help reduce inflammation and scaling. For moderate to severe cases, phototherapy, which involves controlled exposure to ultraviolet light, can be effective. Systemic medications, including methotrexate and biologics, target the immune system to decrease flare-ups and improve overall skin health. Lifestyle modifications, such as stress management and a balanced diet, also play a vital role in managing psoriasis. Collaborating with a dermatologist can help tailor a treatment plan to individual needs, enhancing both skin health and quality of life.
Featured Speakers — Psoriasis Treatments 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Psoriasis Treatments Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Psoriasis Treatments Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Psoriasis Treatments work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Psoriasis Treatments research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same programme, same certificate.
Join IDC 2027 for the Psoriasis Treatments track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Psoriasis Treatments Conference 2027 — FAQs
What is the Psoriasis Treatments track at IDC 2027?
The Psoriasis Treatments track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Psoriasis Treatments. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Psoriasis Treatments sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Psoriasis Treatments are all welcome — whether presenting or attending.
Can I present my research in the Psoriasis Treatments track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Psoriasis Treatments sessions?
Yes. IDC 2027 is a hybrid conference — attend the Psoriasis Treatments track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.